幹細胞の世界市場：洞察、競合情勢、市場予測：2030年

世界の幹細胞の市場規模は、2020年に143億7,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に10.34％のCAGRで拡大し、2030年には258億米ドルに達すると予測されています。幹細胞市場は、様々な慢性疾患の有病率の上昇とその創薬ニーズの高まり、幹細胞研究活動の活発化、遺伝性疾患の症例数の増加、幹細胞治療の世界の普及などにより、プラスの成長を遂げています。加えて、生物製剤に対する需要の増加、この分野における先端製品の開発に対する注目の高まりも、幹細胞の世界市場を牽引する要因の一つです。

幹細胞市場は、様々な理由によって製品需要が伸びていますが、その主な要因の一つは、様々な慢性疾患の有病率の上昇と、その創薬に対する大きなニーズです。1型糖尿病、パーキンソン病、アルツハイマー病などの神経変性疾患の治療法としての細胞移植はすでに研究されています。例えば、2022年1月、BlueRock Therapeutics社による進行性パーキンソン病に対する細胞ベースの治験治療薬DA01の第1相臨床試験において、カナダで最初の患者が投与されました。

これらの疾患における前臨床効果に基づき、この技術は現在、AD、筋萎縮性側索硬化症、ハンチントン病などの他の神経変性疾患にも応用されつつあります。WHOによると、2020年までに慢性疾患の有病率は57％増加すると予測されています。慢性疾患の有病率が増加するにつれて、幹細胞を用いた治療を選択する人が増加し、市場成長の原動力となります。したがって、様々な慢性疾患の蔓延と医薬品開発に関わる研究活動は、ひいては予測期間における幹細胞治療に対する需要の増加につながり、これが幹細胞市場の成長を牽引すると考えられます。

当レポートでは、世界の幹細胞市場について調査し、市場の概要とともに、製品タイプ別、用途別、治療タイプ別、使用法別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 幹細胞市場レポートのイントロダクション

第2章 幹細胞市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本
• 中国

第4章 幹細胞市場の主な要因分析

• 幹細胞市場の促進要因
• 幹細胞市場の抑制要因と課題
• 幹細胞市場の機会

第5章 幹細胞市場におけるポーターのファイブフォース分析

第6章 幹細胞市場に対するCOVID-19の影響分析

第7章 幹細胞市場の概要

• 製品タイプ別
• 用途別
• 治療タイプ別
• 用途別
• 地域別

第8章 幹細胞市場の世界企業シェア分析-主要3～5社

第9章 幹細胞市場の企業と製品プロファイル要

• Osiris Therapeutics, Inc.
• MEDIPOST Co. Ltd.
• Anterogen Co. Ltd.
• Pharmicell Co. Ltd.
• JCR Pharmaceuticals Co. Ltd.
• NuVasive®, Inc.
• Stempeutics Research Pvt Ltd.
• Bristol-Myers Squibb Company
• Organogenesis Inc.
• Takeda Pharmaceutical Company Limited
• CHIESI SAS
• Tegoscience
• Biosolution Co., Ltd.
• CORESTEM, Inc.
• CO.DON
• NIPRO

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis
• Table 3 Stem Cell Market in Global (2018-2030)
• Table 4 Stem Cell Market in Global by Product Type (2018-2030)
• Table 5 Stem Cell Market in Global by Application (2018-2030)
• Table 6 Stem Cell Market in Global by Therapy Type (2018-2030)
• Table 7 Stem Cell Market in Global by Usage (2018-2030)
• Table 8 Stem Cell Market in Global by End User (2018-2030)
• Table 9 Stem Cell Market in Global by Geography (2018-2030)
• Table 10 Stem Cell Market in North America (2018-2030)
• Table 11 Stem Cell Market in North America by Product Type (2018-2030)
• Table 12 Stem Cell Market in North America by Application (2018-2030)
• Table 13 Stem Cell Market in North America by Therapy Type (2018-2030)
• Table 14 Stem Cell Market in North America by Usage (2018-2030)
• Table 15 Stem Cell Market in North America by End User (2018-2030)
• Table 16 Stem Cell Market in North America by Country (2018-2030)
• Table 17 Stem Cell Market in the US (2018-2030)
• Table 18 Stem Cell Market in Canada (2018-2030)
• Table 19 Stem Cell Market in Mexico (2018-2030)
• Table 20 Stem Cell Market in Europe (2018-2030)
• Table 21 Stem Cell Market in Europe by Product Type (2018-2030)
• Table 22 Stem Cell Market in Europe by Application (2018-2030)
• Table 23 Stem Cell Market in Europe by Therapy Type (2018-2030)
• Table 24 Stem Cell Market in Europe by Usage (2018-2030)
• Table 25 Stem Cell Market in Europe by End User (2018-2030)
• Table 26 Stem Cell Market in Europe by Country (2018-2030)
• Table 27 Stem Cell Market in France (2018-2030)
• Table 28 Stem Cell Market in Germany (2018-2030)
• Table 29 Stem Cell Market in the United Kingdom (2018-2030)
• Table 30 Stem Cell Market in Italy (2018-2030)
• Table 31 Stem Cell Market in Spain (2018-2030)
• Table 32 Stem Cell Market in Russia (2018-2030)
• Table 33 Stem Cell Market in Rest of Europe (2018-2030)
• Table 34 Stem Cell Market in APAC (2018-2030)
• Table 35 Stem Cell Market in APAC by Product Type (2018-2030)
• Table 36 Stem Cell Market in APAC by Application (2018-2030)
• Table 37 Stem Cell Market in APAC by Therapy Type (2018-2030)
• Table 38 Stem Cell Market in APAC by Usage (2018-2030)
• Table 39 Stem Cell Market in APAC by End User (2018-2030)
• Table 40 Stem Cell Market in APAC by Country (2018-2030)
• Table 41 Stem Cell Market in China (2018-2030)
• Table 42 Stem Cell Market in Japan (2018-2030)
• Table 43 Stem Cell Market in India (2018-2030)
• Table 44 Stem Cell Market in Australia (2018-2030)
• Table 45 Stem Cell Market in South Korea (2018-2030)
• Table 46 Stem Cell Market in Rest of APAC (2018-2030)
• Table 47 Stem Cell Market in Rest of World (2018-2030)
• Table 48 Stem Cell Market in RoW by Product Type (2018-2030)
• Table 49 Stem Cell Market in RoW by Application (2018-2030)
• Table 50 Stem Cell Market in RoW by Therapy Type (2018-2030)
• Table 51 Stem Cell Market in RoW by Usage (2018-2030)
• Table 52 Stem Cell Market in RoW by End User (2018-2030)
• Table 53 Stem Cell Market in RoW by Region (2018-2030)
• Table 54 Stem Cell Market in Middle East (2018-2030)
• Table 55 Stem Cell Market in Africa (2018-2030)
• Table 56 Stem Cell Market in South America (2018-2030)

List of Figures

• Figure 1 Competitive Analysis
• Figure 2 COVID-19 Impact Analysis
• Figure 3 Stem Cell Market in Global (2018-2030)
• Figure 4 Stem Cell Market in Global by Product Type (2018-2030)
• Figure 5 Stem Cell Market in Global by Application (2018-2030)
• Figure 6 Stem Cell Market in Global by Therapy Type (2018-2030)
• Figure 7 Stem Cell Market in Global by Usage (2018-2030)
• Figure 8 Stem Cell Market in Global by End User (2018-2030)
• Figure 9 Stem Cell Market in Global by Geography (2018-2030)
• Figure 10 Stem Cell Market in North America (2018-2030)
• Figure 11 Stem Cell Market in North America by Product Type (2018-2030)
• Figure 12 Stem Cell Market in North America by Application (2018-2030)
• Figure 13 Stem Cell Market in North America by Therapy Type (2018-2030)
• Figure 14 Stem Cell Market in North America by Usage (2018-2030)
• Figure 15 Stem Cell Market in North America by End User (2018-2030)
• Figure 16 Stem Cell Market in North America by Country (2018-2030)
• Figure 17 Stem Cell Market in the US (2018-2030)
• Figure 18 Stem Cell Market in Canada (2018-2030)
• Figure 19 Stem Cell Market in Mexico (2018-2030)
• Figure 20 Stem Cell Market in Europe (2018-2030)
• Figure 21 Stem Cell Market in Europe by Product Type (2018-2030)
• Figure 22 Stem Cell Market in Europe by Application (2018-2030)
• Figure 23 Stem Cell Market in Europe by Therapy Type (2018-2030)
• Figure 24 Stem Cell Market in Europe by Usage (2018-2030)
• Figure 25 Stem Cell Market in Europe by End User (2018-2030)
• Figure 26 Stem Cell Market in Europe by Country (2018-2030)
• Figure 27 Stem Cell Market in France (2018-2030)
• Figure 28 Stem Cell Market in Germany (2018-2030)
• Figure 29 Stem Cell Market in the United Kingdom (2018-2030)
• Figure 30 Stem Cell Market in Italy (2018-2030)
• Figure 31 Stem Cell Market in Spain (2018-2030)
• Figure 32 Stem Cell Market in Russia (2018-2030)
• Figure 33 Stem Cell Market in Rest of Europe (2018-2030)
• Figure 34 Stem Cell Market in APAC (2018-2030)
• Figure 35 Stem Cell Market in APAC by Product Type (2018-2030)
• Figure 36 Stem Cell Market in APAC by Application (2018-2030)
• Figure 37 Stem Cell Market in APAC by Therapy Type (2018-2030)
• Figure 38 Stem Cell Market in APAC by Usage (2018-2030)
• Figure 39 Stem Cell Market in APAC by End User (2018-2030)
• Figure 40 Stem Cell Market in APAC by Country (2018-2030)
• Figure 41 Stem Cell Market in China (2018-2030)
• Figure 42 Stem Cell Market in Japan (2018-2030)
• Figure 43 Stem Cell Market in India (2018-2030)
• Figure 44 Stem Cell Market in Australia (2018-2030)
• Figure 45 Stem Cell Market in South Korea (2018-2030)
• Figure 46 Stem Cell Market in Rest of APAC (2018-2030)
• Figure 47 Stem Cell Market in Rest of World (2018-2030)
• Figure 48 Stem Cell Market in RoW by Product Type (2018-2030)
• Figure 49 Stem Cell Market in RoW by Application (2018-2030)
• Figure 50 Stem Cell Market in RoW by Therapy Type (2018-2030)
• Figure 51 Stem Cell Market in RoW by Usage (2018-2030)
• Figure 52 Stem Cell Market in RoW by End User (2018-2030)
• Figure 53 Stem Cell Market in RoW by Region (2018-2030)
• Figure 54 Stem Cell Market in Middle East (2018-2030)
• Figure 55 Stem Cell Market in Africa (2018-2030)
• Figure 56 Stem Cell Market in South America (2018-2030)
• Figure 57 Market Drivers
• Figure 58 Market Barriers
• Figure 59 Marker Opportunities
• Figure 60 PORTER'S Five Force Analysis

Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries And Wounds, Cardiovascular Disorders, Others), By Therapy Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy), By Usage (Regenerative Medicine, Drug Discovery And Development), by geography is expected to grow at a steady CAGR forecast till 2030 owing to growing stem cell research activities and need for drug discovery

Global Stem Cell Market was valued at USD 14.37 billion in 2020, growing at a CAGR of 10.34% during the forecast period from 2024 to 2030 to reach USD 25.80 billion by 2030. The Stem Cell market is witnessing positive growth owing to the rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, increasing cases of genetic disorders, significant adoption of stem cell therapies globally. In addition, increasing demand for biologics, accumulative focus on developing advanced products in the arena are some of the factors contributing to the Global Stem Cell Market.

Stem Cell Market Dynamics:

The Stem Cell market is witnessing a growth in product demand owing to various reasons, one of the key factors being the rising prevalence of various chronic diseases and the significant need for their drug discovery. Cell transplantation as a therapy for neurodegenerative disorders such as Diabetes type 1, Parkinson's disease, and Alzheimer's disease among others are already being explored. For instance, in January 2022, the first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy for advanced Parkinson's disease by BlueRock Therapeutics.

Based on the preclinical effect in these diseases, the technique is now being applied to other neurodegenerative disorders, such as AD, amyotrophic lateral sclerosis, and Huntington's disease. According to WHO, by 2020, the prevalence of the chronic disease is predicted to increase by 57%. As the prevalence of chronic disease increases, people opting for stem cell-based treatment will rise, thus driving the market growth. Therefore, the prevalence of various chronic diseases and their research activities involved in drug development, in turn, would lead to an increase in demand for Stem Cell therapies in the forecast period (2024-2030), which will drive the Stem Cell market growth.

Another key factor responsible for the growth of the Stem Cell market is the increasing cases of genetic disorders. As genetic disorders occur due to anomalies of genetic origin, there has been a growing demand for stem cell therapies. Stem Cell therapy holds promise for treating a wide range of diseases, such as Cancer, Neonatal Encephalopathy, among others. For instance, on June 11, 2019, Mesoblast Limited announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for the use of mesenchymal stem cells (MSCs) in the treatment of newborns who lack sufficient blood supply and oxygen to the brain, a condition termed neonatal hypoxic-ischemic encephalopathy (HIE).

Hence, Stem Cell therapy-based biologics have a wide range of applications, from gene replacement to gene knockdown.

Furthermore, stem cell therapy offers a more sustainable treatment approach, thereby becoming one of the popular choices in the management of genetic diseases. This results in a large number of potential stem cell therapies being under clinical development. This indicates the plethora of potential therapies that may reach the market in the coming years. Hence, growing stem cell research activities is another key factor being responsible for further boosting the growth of the Stem Cell market during the forecast period.

Thus, all the aforementioned factors are expected to augment the global market for Stem Cell.

However, ethical issues related to the use of stem cells and the high cost of these therapies is likely to impede the market growth.

Along with the factors mentioned above, the COVID-19 pandemic presented another major opportunity for growth for the manufacturers operating in the biopharmaceutical domain. The effect of the pandemic accelerated the drug development activities for the SARS-Cov-2 virus across the globe. The dire need for developing a vaccine to contain the pandemic led to the approval and emergency use authorization of numerous vaccines for prophylactic use across the globe. Moreover, some of the recent studies have suggested that stem cell therapy has a remarkable effect on reducing mortality and morbidity of patients with COVID-19. Therefore, different candidates under development might prove as a potential therapy for COVID-19 infection.

Stem Cell Market Segment Analysis:

Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, Others), By Therapy Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy), By Usage (Regenerative Medicine, Drug Discovery and Development), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Therapy Type segment of the Stem Cell Market, Allogeneic Stem Cell Therapy is estimated to hold the highest share in the Stem Cell market during the forecast period (2024-2030).

Allogeneic Stem Cell Therapy offers several advantages as they are derived from a donor whose human leukocyte antigens (HLA) are acceptable matches to the patients. The stem cell donor may be related to the patient, or they may be an unrelated volunteer found through a donor registry.

Moreover, the growth of the segment is attributed to the easy process of manufacturing & production and the increasing availability of novel stem cell products across major countries.

Also, this therapy is widely used for treating different types of cancers such as lymphomas, leukemias, and myelomas.

Therefore, considering the advantages associated with Allogeneic Stem Cell Therapy, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Stem Cell market in the forecast period.

North America is expected to dominate the overall Stem Cell Market:

Among all the regions, North America is expected to account for the largest share in the Global Stem Cell market. This can be ascribed to the high focus on therapy development for rare genetic diseases, growing stem cell research activities, a growing focus on the development of personalized medicines, supportive regulatory environment, sophisticated healthcare infrastructure, and increased awareness and product launches regarding new treatments are also expected to aid in the Stem Cell market growth in this region.

One of the key supporting factors for the growth of the North America Stem Cell market is the increasing focus on developing therapies for rare genetic diseases, particularly in the United States. As per the data provided by the US Food and Drug Administration (FDA) (2023), there are more than 7,000 rare diseases that affect more than 30 million people in the United States. The huge number of indications has resulted in a considerable number of companies in the country developing therapeutics aimed at treating genetic diseases. Therefore, the increasing focus of the US FDA and the US government in catering to the medical needs of people suffering from diseases in the country is also expected to drive the North America Stem Cell market in coming years.

Furthermore, an active pipeline by key players being involved in the development of such products is anticipated to fuel the market in the region.

Moreover, the occurrence of various strategic business activities in the region such as company collaborations, acquisitions, product launch, and approval, among others are also expected to propel the market for Stem Cell in the region. For instance, on March 12, 2019, Smith & Nephew plc announced its acquisition of Osiris Therapeutics, Inc., which is a company delivering regenerative medicine products, including skin, bone graft, and articular cartilage substitutes, for approximately USD 660 million. This in turn would provide a conducive growth environment for the North America region.

These kinds of products launched in the local markets will thereby push the product demand in the market. Therefore, the interplay of various factors in the region is expected to boost the North America Stem Cell market during the forecast period.

Stem Cell Market Key Players:

Some of the key market players operating in the Stem Cell market include Osiris Therapeutics, Inc. (Smith+Nephew Inc.), MEDIPOST Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., NuVasive®, Inc., Stempeutics Research Pvt Ltd., Bristol-Myers Squibb Company, Organogenesis Inc., Takeda Pharmaceutical Company Limited, CHIESI SAS, Tegoscience, Biosolution Co., Ltd., CORESTEM, Inc., CO.DON, NIPRO and others.

Recent Developmental Activities in the Stem Cell Market:

On 17 May 2022, MEDIPOST completed the expansion of its production facilities for its knee osteoarthritis stem cell products, CARTISTEM® and SMUP-IA-01, and will start to prepare for GMP (Good Manufacturing Practice) certification.

On February 5, 2022, Bristol Myers won FDA approval for its cancer cell therapy, Breyanzi, for the treatment of late-stage lymphoma.

In August 2020, Cipla Limited announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved globally for CLI treatment.

Key Takeaways from the Stem Cell Market Report Study

• Market size analysis for current Stem Cell market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Stem Cell market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Stem Cell market.
• Various opportunities available for the other competitor in the Stem Cell market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Stem Cell market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Stem Cell market growth in the coming future?

Target Audience who can be benefited from this Stem Cell Market Report Study

• Stem Cell products providers
• Research organizations and consulting companies
• Stem Cell-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Stem Cell
• Various End-users who want to know more about the Stem Cell market and latest technological developments in the Stem Cell market.

Frequently Asked Questions for Stem Cell Market:

1. What is Stem Cell Therapy?

Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. It is the next step in organ transplantation and uses cells instead of donor organs, which are limited in supply.

2. What is the market for Global Stem Cell?

Global Stem Cell Market was valued at USD 14.37 billion in 2020, growing at a CAGR of 10.34% during the forecast period from 2024 to 2030 to reach USD 25.80 billion by 2030.

3. What are the drivers for Global Stem Cell Market?

The Stem Cell market is witnessing a positive market growth owing to the rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, increasing cases of genetic disorders, significant adoption of stem cell therapies globally. In addition, increasing demand for biologics, accumulative focus on developing advanced products in the arena.

4. Who are the key players operating in the Global Stem Cell Market?

Some of the key market players operating in the Stem Cell market include Osiris Therapeutics, Inc. (Smith+Nephew Inc.), MEDIPOST Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., NuVasive®, Inc., Stempeutics Research Pvt Ltd., Bristol-Myers Squibb Company, Organogenesis Inc., Takeda Pharmaceutical Company Limited, CHIESI SAS, Tegoscience, Biosolution Co., Ltd., CORESTEM, Inc., CO.DON, NIPRO, and others.

5. Which region has the highest share in the Stem Cell Market?

North America is expected to hold the highest share in the revenue in the Stem Cell market during the forecast period. This can be ascribed to the high focus on therapy development for rare genetic diseases, growing stem cell research activities, a growing focus on the development of personalized medicines, supportive regulatory environment, sophisticated healthcare infrastructure, and increased awareness and product launches regarding new treatments are also expected to aid in the Stem Cell market growth in this region.

Table of Contents

1.Stem Cell Market Report Introduction

2.Stem Cell Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Stem Cell Market Key Factors Analysis

• 4.1 Stem Cell Market Drivers
  • 4.1.1 The Rising Prevalence of various Chronic Diseases and the need for their Drug Discovery
  • 4.1.2 Growing Stem Cell Research Activities
  • 4.1.3 Advancements in Product Development
• 4.2 Stem Cell Market Restraints and Challenges
  • 4.2.1 Ethical Issues related to the Use of Stem Cells
  • 4.2.2 The High Cost of Procedures
• 4.3 Stem Cell Market Opportunities
  • 4.3.1 Rising Strategic Business Activities among the Manufacturers
  • 4.3.2 Targeting Emerging Markets for Product Launches

5. Stem Cell Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Stem Cell Market

7. Stem Cell Market Layout

• 7.1 By Product Type
  • 7.1.1 Adult Stem Cell
  • 7.1.2 Human Embryonic Cell
  • 7.1.3 Pluripotent Stem Cell
  • 7.1.4 Others
• 7.2 By Application
  • 7.2.1 Neurological Disorders
  • 7.2.2 Orthopedic Treatments
  • 7.2.3 Oncology Disorders
  • 7.2.4 Injuries and Wounds
  • 7.2.5 Cardiovascular Disorders
  • 7.2.6 Others
• 7.3 By Therapy Type
  • 7.3.1 Allogeneic Stem Cell Therapy
  • 7.3.2 Autologic Stem Cell Therapy
• 7.4 By Usage
  • 7.4.1 Regenerative Medicine
  • 7.4.2 Drug Discovery and Development
• 7.5 By Geography
  • 7.5.1 North America
    • 7.5.1.1 North America Stem Cell Market, by Product Type
    • 7.5.1.2 North America Stem Cell Market, by Application
    • 7.5.1.3 North America Stem Cell Market, by Therapy Type
    • 7.5.1.4 North America Stem Cell Market, by Usage
    • 7.5.1.5 North America Stem Cell Market, by Country
    • 7.5.1.5.1 United States
    • 7.5.1.5.2 Canada
    • 7.5.1.5.3 Mexico
  • 7.5.2 Europe
    • 7.5.2.1 Europe Stem Cell Market, by Product Type
    • 7.5.2.2 Europe Stem Cell Market, by Application
    • 7.5.2.3 Europe Stem Cell Market, by Therapy Type
    • 7.5.2.4 Europe Stem Cell Market, by Usage
    • 7.5.2.5 Europe Stem Cell Market, by Country
    • 7.5.2.5.1 France
    • 7.5.2.5.2 Germany
    • 7.5.2.5.3 United Kingdom
    • 7.5.2.5.4 Italy
    • 7.5.2.5.5 Spain
    • 7.5.2.5.6 Russia
    • 7.5.2.5.7 Rest of Europe
  • 7.5.3 Asia-Pacific
    • 7.5.3.1 Asia-Pacific Stem Cell Market, by Product Type
    • 7.5.3.2 Asia-Pacific Stem Cell Market, by Application
    • 7.5.3.3 Asia-Pacific Stem Cell Market, by Therapy Type
    • 7.5.3.4 Asia-Pacific Stem Cell Market, by Usage
    • 7.5.3.5 Asia-Pacific Stem Cell Market, by Country
    • 7.5.3.5.1 China
    • 7.5.3.5.2 Japan
    • 7.5.3.5.3 India
    • 7.5.3.5.4 Australia
    • 7.5.3.5.5 South Korea
    • 7.5.3.5.6 Rest of Asia Pacific
  • 7.5.4 Rest of the World (RoW)
    • 7.5.4.1 RoW Stem Cell Market, by Product Type
    • 7.5.4.2 RoW Stem Cell Market, by Application
    • 7.5.4.3 RoW Stem Cell Market, by Therapy Type
    • 7.5.4.4 RoW Stem Cell Market, by Usage
    • 7.5.4.5 RoW Stem Cell Market, by Region
    • 7.5.4.5.1 Middle East
    • 7.5.4.5.2 Africa
    • 7.5.4.5.3 South America

8. Stem Cell Market Global Company Share Analysis - Key 3-5 Companies

9. Stem Cell Market Company and Product Profiles

• 9.1 Osiris Therapeutics, Inc. (Smith+Nephew Inc.)
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 MEDIPOST Co. Ltd.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Anterogen Co. Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 Pharmicell Co. Ltd.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 JCR Pharmaceuticals Co. Ltd.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 NuVasive®, Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Stempeutics Research Pvt Ltd.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Bristol-Myers Squibb Company
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Organogenesis Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 Takeda Pharmaceutical Company Limited
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 CHIESI SAS
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 Tegoscience
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 Biosolution Co., Ltd.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 CORESTEM, Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 CO.DON
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy
• 9.16 NIPRO
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4 Product Listing
  • 9.16.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us